Table 2 Previously reported cases of secondary adrenal insufficiency associated with pembrolizumab treatment
Age | Sex | Disease | Therapeutic agents | Onset | Description of pituitary imaging |
|---|---|---|---|---|---|
60 | male | lung cancer | pembrolizumab cisplatin pemetrexed | 15 months after stopping pembrolizumab | no pituitary gland enlargement |
55 | female | breast cancer | pembrolizumab nab-paclitaxel carboplatin adriamycin cyclophosphamide | 6 months after stopping pembrolizumab | no pituitary metastasis |